With the onset of the COVID-19 pandemic, one innovation-driven sponsor recognised the potential of one of its drug products in fighting COVID-19.
The pressure was on to rapidly setup a robust supply chain operation and deliver potentially lifesaving treatment to hundreds of patients at sites across the United States and Europe.
Read our latest case study to understand how by utilising Almac Adapt Just in Time Manufacturing, the sponsor was able to:
- Accelerate study startup and meet aggressive timelines
- Deliver initial supply to hundreds of critically ill COVID-19 patients in record time
- Overcome regulatory roadblocks and government-imposed travel restrictions